Blue Owl Capital Reports 2025 Results, Announces New $300M Share Repurchase Program, $400M Asset Sale, and Q1 2026 Dividend

summarizeSummary

Blue Owl Capital Corporation filed its annual 10-K, reporting increased investment income but lower EPS for 2025, alongside a major merger, significant share repurchases, and new announcements for a $300M share repurchase program and a $400M asset sale.

check_boxKey Events

• Financial Performance for 2025

  Reported total investment income of $1.85 billion and net investment income after taxes of $800.4 million for the year ended December 31, 2025, up from $1.60 billion and $741.1 million respectively in 2024. However, earnings per share decreased to $1.24 in 2025 from $1.53 in 2024.

• Completed OBDE Merger

  On January 13, 2025, the company completed its acquisition of Blue Owl Capital Corporation III (OBDE), issuing approximately 120.6 million shares of common stock. This merger significantly increased the company's investment portfolio to $16.47 billion at fair value in 2025 from $13.19 billion in 2024.

• New $300M Share Repurchase Program

  On February 17, 2026, the Board approved a new share repurchase program authorizing up to $300 million of common stock repurchases, replacing the prior $200 million program under which $148.2 million was repurchased in late 2025.

• Significant Asset Sale Announced

  On February 18, 2026, the company entered into agreements to sell a portion of its portfolio company investments totaling $400 million in commitments, with an aggregate fair value of $357.6 million. Proceeds are intended for debt repayment.

auto_awesomeAnalysis

Blue Owl Capital Corporation's annual 10-K filing reveals a year of significant capital management and portfolio expansion. While net investment income increased, earnings per share saw a decline. The company actively managed its capital structure through a major merger, substantial share repurchases, and debt repayments. The announcement of a new, larger share repurchase program and a significant asset sale on the same day as the filing indicates a proactive approach to optimizing its balance sheet and returning value to shareholders. Investors should monitor the execution of these capital allocation strategies and their impact on future earnings and portfolio performance.